Jean‐Michel Karsenti

Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up

Jérôme Paillassa, Édouard Cornet, Stéphanie Noël et al. · Blood Cancer Journal · 2020 · 59 citations · Full text

Medicine, Oncology, Pharmacology +13

Single Treatment with Rituximab Monotherapy for Low-Tumor Burden Follicular Lymphoma (FL): Survival Analyses with Extended Follow-Up (F/Up) of 7 Years.

Philippe Colombat, Nicole Brousse, Franck Morschhauser et al. · Blood · 2006 · 50 citations

Medicine, Immunology, Oncology +9

All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to Ponatinib

Ophélie Cassuto, Maeva Dufies, Arnaud Jacquel et al. · Oncotarget · 2012 · 34 citations · Full text

Medicine, Oncology, Pharmacology +15

BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice

Mohamed-Amine Hamouda, Arnaud Jacquel, Guillaume Robert et al. · The Journal of Experimental Medicine · 2016 · 31 citations · Full text

Medicine, Cell Biology, Oncology +15

Azacitidine-resistant SKM1 myeloid cells are defective for AZA-induced mitochondrial apoptosis and autophagy

Thomas Cluzeau, Guillaume Robert, Alexandre Puissant et al. · Cell Cycle · 2011 · 28 citations · Full text

Life Sciences, Oncology, Pharmacology +17